Bicalutamide

Drug Profile

Bicalutamide

Alternative Names: Casodex; Cosudex; ICI 176334; ICI176,334-1

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AstraZeneca
  • Class Anilides; Antiandrogens; Antineoplastics; Nitriles; Small molecules; Tosyl compounds
  • Mechanism of Action Testosterone congener inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Prostate cancer

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 26 May 2015 Launched for Prostate cancer in Bahrain (PO)
  • 30 Sep 2011 AstraZeneca completes a phase I trial in Healthy volunteers in Japan (NCT01415791)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top